Wellstart
Wellstart Medical LLC is a nationally approved Medicare DME supplier that distributes third-party CGM and insulin pump supplies to Medicare beneficiaries with diabetes, handling insurance paperwork, prior authorizations, home delivery, and 90-day reorders.
- Company typePrivate
- Founded2019
- HeadquartersPort St. Lucie, United States
- Headcount51–100
- GTM typeB2C
- OfferingServices
What Wellstart does
Wellstart Medical LLC is a Port St. Lucie, Florida-based Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) supplier focused exclusively on diabetes care. Founded in 2019 and operating as a privately held LLC with 11–50 employees, the company distributes continuous glucose monitors (CGMs) and insulin pump supplies from third-party manufacturers — including Dexcom (G7 15-Day, G7, G6), Abbott FreeStyle Libre (Libre 3 Plus, Libre 2 Plus, 14-day), Tandem (T:slim X2, Mobi), and Beta Bionics (iLet) — directly to Medicare beneficiaries' homes.
The company does not develop the underlying diabetes technology; its core capability is administrative coordination and logistics. Wellstart manages the full supply workflow on behalf of patients: receiving physician prescriptions, handling insurance forms and prior authorizations, confirming Medicare and other payer coverage, processing reorders on roughly 90-day cycles, shipping supplies via national carrier, and providing ongoing technical support. Support is led by a Certified Diabetes Care and Education Specialist (CDCES) and includes specialists who themselves live with diabetes, positioning the team as both clinically credentialed and patient-experienced.
Wellstart operates as a direct-to-consumer supplier with a hybrid acquisition model: physician referrals (doctors send prescriptions directly), patient self-referrals (phone or online sign-up via portal.wellstart.com), and paid digital advertising through Google Ads and Meta. Marketing and retention channels include a 24/7 patient portal, US-based toll-free phone support, and SMS notifications for order updates and reorder reminders. The company is WCAG 2.1 Level AA accessibility-compliant and restricts SMS services to U.S. phone numbers, reflecting its national Medicare-focused footprint with no current international expansion.
Wellstart firmographics
Firmographics- Name
- Wellstart
- Legal name
- Wellstart Medical LLC
- Website
- https://wellstart.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Wellstart Medical LLC is a nationally approved Medicare DME supplier that distributes third-party CGM and insulin pump supplies to Medicare beneficiaries with diabetes, handling insurance paperwork, prior authorizations, home delivery, and 90-day reorders.
- Ownership category
- akta.pro rank
Wellstart industry classification
Industry- Product category
- Diabetes Durable Medical Equipment
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Insulin Pumps & Patch Pumps (HLAHAIAG)
- akta.pro secondary industries
- Automated Insulin Delivery (AID) / Closed-Loop Systems (HLAHAHAF), Insulin Pen Needles, Syringes & Infusion Sets (Consumables) (HLAHAHAE)
Keywords
Where Wellstart is headquartered
LocationHeadquarters
- HQ city
- Port St. Lucie
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Wellstart business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Medicare DME Supply Revenue: Wellstart generates revenue as a nationally approved Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) supplier. The company bills Medicare and other insurance plans for CGM systems and insulin pump supplies. Patients pay co-insurance, deductibles, and any balance due according to their insurance coverage. Most insurance plans allow reorders every 90 days.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Pay-as-you-go | Insurance/Medicare-covered diabetes supplies with patient cost-sharing |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
Wellstart product offering
Product offeringCore offering
Wellstart is a Medicare-approved DMEPOS supplier that distributes continuous glucose monitors and insulin pump systems directly to Medicare patients' homes. The company supplies CGMs from Dexcom (G7 15-day, G7, G6) and Abbott FreeStyle Libre (3 Plus, 2 Plus, 14-day) and insulin pumps from Tandem (T:Slim, Mobi) and Beta Bionics (iLet). It manages all administrative coordination—working with prescribing physicians, processing insurance claims, obtaining prior authorizations—and delivers supplies via national carrier, with reorders typically processed every 90 days.
Product overview
Wellstart Medical is a Medicare DME supplier providing a portfolio of diabetes care products centered on continuous glucose monitors (CGMs) and insulin pump systems. The core product offering consists of six CGM devices from Dexcom (G7 15-Day, G7, G6) and Abbott FreeStyle Libre (Libre 3 Plus, Libre 2 Plus, Libre 14-Day), plus three insulin pump systems from Tandem (T:Slim, Mobi) and Beta Bionics (iLet). These products are distributed through a patient portal and phone-based reorder system, with services including insurance coordination, paperwork handling with doctors, delivery tracking, and ongoing support from diabetes care specialists. The portfolio serves Medicare patients requiring diabetes supplies management.
Differentiator
Problem solved
Functional benefit
Products and services
- Dexcom G7 15-day Continuous Glucose Monitor Continuous glucose monitor offering fast, accurate glucose readings with an extended 15-day wear time to support convenience, fewer supply changes, and less waste. Distributed by Wellstart to Medicare patients with diabetes.
- FreeStyle Libre 3 Plus Continuous glucose monitoring system providing continuous glucose level monitoring without frequent finger pricks. Distributed by Wellstart to Medicare patients with diabetes.
- Dexcom G7 Continuous Glucose Monitor Continuous glucose monitor offering fast, accurate glucose readings for diabetes management. Distributed by Wellstart to Medicare patients.
- FreeStyle Libre 2 Plus Continuous glucose monitoring system with optional real-time alarms for low and high glucose events. Distributed by Wellstart to Medicare patients.
- Dexcom G6 Continuous Glucose Monitor Continuous glucose monitoring system providing real-time glucose readings and trend arrows to help manage diabetes. Distributed by Wellstart to Medicare patients.
- FreeStyle Libre 14-day Continuous glucose monitoring system with 14-day sensor wear for glucose monitoring. Distributed by Wellstart to Medicare patients.
- Tandem T:Slim Insulin Pump Insulin pump with automated insulin delivery capabilities for precise diabetes management. Distributed by Wellstart to Medicare patients.
- Tandem Mobi Automated Insulin Delivery System Automated insulin delivery system offering compact design and advanced diabetes management features. Distributed by Wellstart to Medicare patients.
- Beta Bionics iLet Bionic Pancreas Automated insulin delivery system designed for intuitive diabetes management. Distributed by Wellstart to Medicare patients.
- Wellstart Patient Portal Online platform for managing supplies, reordering, tracking order status, updating insurance information, and accessing account features. Available 24/7 for Medicare patients.
Companies that use Wellstart
Customer profileSegments1 record
Ideal customer profiles1 record
Wellstart technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Wellstart partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- DexcomcoreDexcom is a primary product partner for Wellstart. Wellstart distributes Dexcom continuous glucose monitors including the Dexcom G7 (10-day), Dexcom G7 15-day, and Dexcom G6. Wellstart provides patient support including troubleshooting, setup guidance, and helps patients with software updates such as the G7 receiver update required for the new 15-day sensor.
- Abbott (FreeStyle Libre)coreAbbott FreeStyle Libre is a primary product partner. Wellstart distributes FreeStyle Libre products including Libre 3 Plus, Libre 2 Plus, Libre 14-day, and handles support for FreeStyle Libre sensors including assistance with sensor replacement requests and troubleshooting. Wellstart communicates Abbott product corrections to patients (e.g., FreeStyle Libre 3/Libre 3 Plus sensor correction for incorrect low glucose readings).
- Tandem Diabetes CarecoreTandem Diabetes Care is a product partner for insulin pump systems. Wellstart distributes Tandem products including the Tandem T:slim X2 insulin pump and Tandem Mobi automated insulin delivery system.
- Beta BionicscoreBeta Bionics is a product partner for the iLet insulin pump system. Wellstart distributes the Beta Bionics iLet bionic pancreas, an automated insulin delivery system for diabetes management.
Scale indicators3 records
Recent moves6 records
Expansion highlights4 records
Wellstart competitors and assessment
Company assessmentDirect peers
- Solara Medical Supplies: Solara Medical Supplies is a Medicare-accredited DME distributor focused on diabetes CGMs and insulin pump therapy, offering paperwork handling and home delivery. It serves the same Medicare beneficiary population as Wellstart with overlapping manufacturer partnerships.
- Byram Healthcare: Byram Healthcare (now part of Owens & Minor) is a national Medicare DME supplier with a leading diabetes supplies business, distributing CGMs and insulin pump supplies. Like Wellstart, it bills Medicare/insurance directly and handles paperwork, prior authorizations, and home delivery for chronic care patients.
- US Med: US Med is a Medicare-accredited DME supplier specializing in diabetes supplies (CGMs, insulin pumps, test strips). It targets a similar Medicare patient population with recurring 90-day supply delivery and direct insurance billing—overlapping almost entirely with Wellstart's core offering.
- Edgepark Medical Supplies: Edgepark (a Cardinal Health company) is a long-standing DME distributor serving patients with diabetes, urological, ostomy, and other supplies via insurance billing. It competes with Wellstart for Medicare CGM and insulin pump patients through a similar direct-to-patient ordering model.
- CCS Medical: CCS Medical is a national DME distributor serving Medicare and commercial patients with diabetes, urological, and wound care supplies. Its diabetes segment distributes CGMs and pump supplies via insurance billing with home delivery—a near-direct overlap with Wellstart.
Broad incumbents
- Apria Healthcare: Apria Healthcare (now part of Owens & Minor) is a major DME provider with respiratory, sleep, and diabetes supply lines. Its diabetes business overlaps with Wellstart's Medicare supply model, though Apria operates at far greater scale and breadth.
- AdaptHealth: AdaptHealth is a large, publicly traded DME provider offering diabetes supplies, sleep therapy, respiratory equipment, and HME across the U.S. While broader in scope, its diabetes segment directly competes with Wellstart for Medicare CGM and insulin pump patients.
Others
- Abbott Diabetes Care: Abbott manufactures the FreeStyle Libre CGM family distributed by Wellstart. Abbott operates direct-to-patient programs but depends on Medicare DME suppliers like Wellstart for a significant share of Medicare fulfillment.
- Dexcom: Dexcom is the leading CGM manufacturer and a primary product supplier/partner for Wellstart. While Dexcom sells direct via its own channels, it relies on DME distributors like Wellstart to reach Medicare patients—an ecosystem relationship rather than a direct competitor.
- Tandem Diabetes Care: Tandem Diabetes Care manufactures the t:slim X2 and Tandem Mobi insulin pumps distributed by Wellstart. As a manufacturer-partner rather than direct competitor, Tandem's commercial decisions directly affect Wellstart's pump supply revenue.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Wellstart social profiles
Digital presenceWellstart financial estimates
Financial estimateRevenue estimate
Valuation estimate
Wellstart leadership team
Management profileNumber of profiles
Wellstart funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Wellstart M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Wellstart
What does Wellstart do?
Wellstart is a Medicare-approved DMEPOS supplier that distributes continuous glucose monitors and insulin pump systems directly to Medicare patients' homes. The company supplies CGMs from Dexcom (G7 15-day, G7, G6) and Abbott FreeStyle Libre (3 Plus, 2 Plus, 14-day) and insulin pumps from Tandem (T:Slim, Mobi) and Beta Bionics (iLet). It manages all administrative coordination—working with prescribing physicians, processing insurance claims, obtaining prior authorizations—and delivers supplies via national carrier, with reorders typically processed every 90 days.
Is Wellstart a public or private company?
Wellstart is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Wellstart founded?
Wellstart was founded in 2019. It employs 51 to 100 people.
Where is Wellstart based?
Wellstart is headquartered in Port St. Lucie, United States, in the North America region.
How does Wellstart make money?
One revenue line is on record: medicare DME Supply Revenue.
Who are Wellstart's main competitors?
Direct peers on record are Solara Medical Supplies, Byram Healthcare, US Med, Edgepark Medical Supplies and CCS Medical. Broad incumbents are Apria Healthcare and AdaptHealth. Others are Abbott Diabetes Care, Dexcom and Tandem Diabetes Care.
Does Wellstart have an API?
No public API is recorded for Wellstart.
What industry is Wellstart in?
Wellstart's product category is Diabetes Durable Medical Equipment. Its primary akta.pro industry code is HLAHAIAG, Insulin Pumps & Patch Pumps, with a secondary code of HLAHAHAF, Automated Insulin Delivery (AID) / Closed-Loop Systems. Its SIC code is 5122.